Loading…
Lobbying Spend
—
Filings
11
Firms Hired
1
Active Period
2011–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3630
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5651
Federal Aviation Administration Extension Act of 2010
2013 · first_quarter · Firm: C2 GROUP, LLC
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: — · Firm income: $50,000
Matched citations: S.3187
Carson National Forest Boundary Adjustment Act of 2013
2013 · first_quarter · Firm: C2 GROUP, LLC
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: — · Firm income: $50,000
Matched citations: S.312
Fairness to Pet Owners Act of 2011
2012 · fourth_quarter · Firm: C2 GROUP, LLC
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act, H.R. 1406.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1406
Food and Drug Administration Reform Act of 2012
2012 · fourth_quarter · Firm: C2 GROUP, LLC
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act, H.R. 1406.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5651
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act, H.R. 1406.
Client expense: — · Firm income: $60,000
Matched citations: H.R.605
Food and Drug Administration Reform Act of 2012
2012 · third_quarter · Firm: C2 GROUP, LLC
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5651
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187.
Client expense: — · Firm income: $60,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC.
Client expense: — · Firm income: $60,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC.
Client expense: — · Firm income: $60,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.
Client expense: — · Firm income: $50,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.
Client expense: — · Firm income: $50,000
Matched citations: H.R.605
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.
Client expense: — · Firm income: $50,000
Matched citations: H.R.605
FSA Changes, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA Reform; PDUFA
Client expense: — · Firm income: $50,000
Matched citations: H.R.605
Source: Senate LDA